Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Accumulated Expenses (2016 - 2018)

Historic Accumulated Expenses for Armata Pharmaceuticals (ARMP) over the last 5 years, with Q3 2018 value amounting to $1.8 million.

  • Armata Pharmaceuticals' Accumulated Expenses rose 5292.58% to $1.8 million in Q3 2018 from the same period last year, while for Sep 2018 it was $1.8 million, marking a year-over-year increase of 5292.58%. This contributed to the annual value of $1.0 million for FY2017, which is 1731.84% up from last year.
  • Per Armata Pharmaceuticals' latest filing, its Accumulated Expenses stood at $1.8 million for Q3 2018, which was up 5292.58% from $1.4 million recorded in Q2 2018.
  • In the past 5 years, Armata Pharmaceuticals' Accumulated Expenses ranged from a high of $1.8 million in Q3 2018 and a low of $10000.0 during Q3 2016
  • In the last 5 years, Armata Pharmaceuticals' Accumulated Expenses had a median value of $728000.0 in 2015 and averaged $719294.1.
  • As far as peak fluctuations go, Armata Pharmaceuticals' Accumulated Expenses plummeted by 9796.33% in 2016, and later soared by 1135000.0% in 2017.
  • Quarter analysis of 5 years shows Armata Pharmaceuticals' Accumulated Expenses stood at $457000.0 in 2014, then surged by 59.3% to $728000.0 in 2015, then rose by 22.94% to $895000.0 in 2016, then increased by 17.32% to $1.0 million in 2017, then surged by 66.76% to $1.8 million in 2018.
  • Its Accumulated Expenses stands at $1.8 million for Q3 2018, versus $1.4 million for Q2 2018 and $965000.0 for Q1 2018.